ConductScience.org, home

Paper22856463

Effects of intensified conditioning on Epstein-Barr virus and cytomegalovirus infections in allogeneic hematopoietic stem cell transplantation for hematological malignancies.

Xuan L and 9 others. J Hematol Oncol, 2012. Cited by 75 papers, by iCite.

Cite this record

ConductScience Library. Effects of intensified conditioning on Epstein-Barr virus and cytomegalovirus infections in allogeneic hematopoietic stem cell transplantation for hematological malignancies. Papers, record 22856463. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/22856463

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Effects of intensified conditioning on Epstein-Barr virus and cytomegalovirus infections in allogeneic hematopoietic stem cell transplantation for hematological malignancies.
PubMed
Journal
J Hematol Oncol
PubMed
Year
2012
PubMed
Publication types
Clinical Trial, Journal Article, Research Support, Non-U.S. Gov't
PubMed
Citations, by iCite
75
iCite
Relative citation ratio, by iCite
2.59
iCite
Revised in PubMed
2024-03-21
PubMed

Authors10

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Xuan LLi
2Huang FFen
3Fan ZZhiping
4Zhou HHongsheng
5Zhang XXian
6Yu GGuopan
7Zhang YYu
8Liu CCan
9Sun JJing
10Liu QQifa

Source PubMed

Download CSV of authors

Topics26

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Cytomegalovirus InfectionsMajor topic
Epstein-Barr Virus InfectionsMajor topic
Hematologic NeoplasmsMajor topic
Hematopoietic Stem Cell TransplantationMajor topic
Transplantation ConditioningMajor topic
Adolescent
Adult
Child
Cytomegalovirus
DNA, Viral
Female
Flow Cytometry
Graft vs Host Disease
Herpesvirus 4, Human
Humans
Male
Middle Aged
Prognosis
Prospective Studies
RNA, Messenger
Real-Time Polymerase Chain Reaction
Risk Factors
Survival Rate
Transplantation, Homologous
Viremia
Young Adult

Source PubMed

Download CSV of topics

References37

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
120970670Reactivations of cytomegalovirus, human herpes virus 6, and Epstein-Barr virus differ with respect to risk factors and clinical outcome after hematopoietic stem cell transplantation.Transplant Proc2010https://conductscience.org/library/papers/20970670PubMed
219264919Risk factors for lymphoproliferative disorders after allogeneic hematopoietic cell transplantation.Blood2009https://conductscience.org/library/papers/19264919PubMed
321997849Cytomegalovirus infection and disease after allogeneic hematopoietic stem cell transplantation: experience in a center with a high seroprevalence of both CMV and hepatitis B virus.Ann Hematol2012https://conductscience.org/library/papers/21997849PubMed
420482561Prospective study of infectious complications in allogeneic hematopoietic stem cell transplant recipients.Clin Transplant2011https://conductscience.org/library/papers/20482561PubMed
511801465Standard versus alternative myeloablative conditioning regimens in allogeneic hematopoietic stem cell transplantation for high-risk acute leukemia.Haematologica2002https://conductscience.org/library/papers/11801465PubMed
611157478Melphalan and purine analog-containing preparative regimens: reduced-intensity conditioning for patients with hematologic malignancies undergoing allogeneic progenitor cell transplantation.Blood2001https://conductscience.org/library/papers/11157478PubMed
717448963Risk assessment in haematopoietic stem cell transplantation: conditioning.Best Pract Res Clin Haematol2007https://conductscience.org/library/papers/17448963PubMed
819497070Targeted monitoring of patients at high risk of post-transplant lymphoproliferative disease by quantitative Epstein-Barr virus polymerase chain reaction.Transpl Infect Dis2009https://conductscience.org/library/papers/19497070PubMed
917921853Human herpesvirus 6 (HHV-6)-associated pleurisy after unrelated cord blood transplantation in children with chemotherapy-resistant malignant Lymphoma.J Pediatr Hematol Oncol2007https://conductscience.org/library/papers/17921853PubMed
1022424172Allogeneic hematopoietic stem cell transplantation in China: where we are and where to go.J Hematol Oncol2012https://conductscience.org/library/papers/22424172PubMed
1114576063Dose-escalated donor lymphocyte infusions following reduced intensity transplantation: toxicity, chimerism, and disease responses.Blood2004https://conductscience.org/library/papers/14576063PubMed
1211877269Incidence and outcome of cytomegalovirus infections following nonmyeloablative compared with myeloablative allogeneic stem cell transplantation, a matched control study.Blood2002https://conductscience.org/library/papers/11877269PubMed
1319043458Management of HSV, VZV and EBV infections in patients with hematological malignancies and after SCT: guidelines from the Second European Conference on Infections in Leukemia.Bone Marrow Transplant2009https://conductscience.org/library/papers/19043458PubMed
148652385
A comparison of busulphan versus total body irradiation combined with cyclophosphamide as conditioning for autograft or allograft bone marrow transplantation in patients with acute leukaemia. Acute Leukaemia Working Party of the European Group for Blood and Marrow Transplantation (EBMT).
Br J Haematol1996https://conductscience.org/library/papers/8652385PubMed
1521323694The impact of early viral infections and graft-versus-host disease on immune reconstitution following paediatric stem cell transplantation.Scand J Immunol2011https://conductscience.org/library/papers/21323694PubMed
1616151426Cause of death after allogeneic haematopoietic stem cell transplantation (HSCT) in early leukaemias: an EBMT analysis of lethal infectious complications and changes over calendar time.Bone Marrow Transplant2005https://conductscience.org/library/papers/16151426PubMed
1715090449
Nonablative versus reduced-intensity conditioning regimens in the treatment of acute myeloid leukemia and high-risk myelodysplastic syndrome: dose is relevant for long-term disease control after allogeneic hematopoietic stem cell transplantation.
Blood2004https://conductscience.org/library/papers/15090449PubMed
1822856463Effects of intensified conditioning on Epstein-Barr virus and cytomegalovirus infections in allogeneic hematopoietic stem cell transplantation for hematological malignancies.J Hematol Oncol2012https://conductscience.org/library/papers/22856463PubMed
1912171713Allogeneic hematopoietic cell transplantation without myeloablative conditioning for patients with advanced hematologic malignancies.Cytotherapy2001https://conductscience.org/library/papers/12171713PubMed
2018300756Novel strategies for relapsed and refractory acute myeloid leukemia.Curr Opin Hematol2008https://conductscience.org/library/papers/18300756PubMed

See all 37 referencesDownload CSV of references

Cited by53

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 75 citations.

PMIDTitleJournalYearIn PapersSource
42237268Impact of RUNX1 mutations at distinct sites on the clinical characteristics and prognosis of patients with acute myeloid leukemia.BMC Cancer2026https://conductscience.org/library/papers/42237268PubMed
42056205Letermovir prophylaxis and early CMV DNAemia after allogeneic hematopoietic stem cell transplantation: a real‑world study from China.Sci Rep2026https://conductscience.org/library/papers/42056205PubMed
41550532
Efficacy and safety of Busulfan-Fludarabine versus Busulfan-Cyclophosphamide as a conditioning regimen prior to hematopoietic stem cell transplant in hematologic malignancy patients: a meta-analysis of randomized controlled trials and observational studies.
Ther Adv Hematol2026https://conductscience.org/library/papers/41550532PubMed
41122689Increased EBV infection and relapse following haploidentical hematopoietic cell transplantation in the era of letermovir for cytomegalovirus prophylaxis: a propensity score matching analysis.Front Cell Infect Microbiol2025https://conductscience.org/library/papers/41122689PubMed
39746694[Maribavir treatment for refractory and drug-intolerant cytomegalovirus viremia and disease after allogeneic hematopoietic stem cell transplantation: a clinical analysis of 25 cases].Zhonghua Xue Ye Xue Za Zhi2024https://conductscience.org/library/papers/39746694PubMed
39746692[Early cellular immune exhaustion in patients with Epstein-Barr virus activation following haploidentical hematopoietic stem cell transplantation].Zhonghua Xue Ye Xue Za Zhi2024https://conductscience.org/library/papers/39746692PubMed
39398542CD34+ cell dose and CMV viremia after haploidentical hematopoietic stem cell transplantation: a retrospective study.Am J Transl Res2024https://conductscience.org/library/papers/39398542PubMed
39390260Epstein-Barr virus as a potentiator of autoimmune diseases.Nat Rev Rheumatol2024https://conductscience.org/library/papers/39390260PubMed
39360328Cytomegalovirus results in poor graft function via bone marrow-derived endothelial progenitor cells.Front Microbiol2024https://conductscience.org/library/papers/39360328PubMed
39077735The impact of the donors' COVID-19 status on the outcomes of allogeneic hematopoietic stem cell transplantation: a multi-center retrospective study.Front Microbiol2024https://conductscience.org/library/papers/39077735PubMed
38856035T-Cell Posttransplant Lymphoproliferative Disorders After Allogeneic Hematopoietic Stem Cell Transplantation: Case Series and Systemic Review.Cell Transplant2024https://conductscience.org/library/papers/38856035PubMed
38680718Rate, Risk Factors, and Outcomes of Invasive Fungal Infections in Patients with Hematologic Malignancies.Int J Hematol Oncol Stem Cell Res2024https://conductscience.org/library/papers/38680718PubMed
37875840Influence on therapeutic outcome of platelet count at diagnosis in patients with de novo non-APL acute myeloid leukemia.BMC Cancer2023https://conductscience.org/library/papers/37875840PubMed
37474631Ruxolitinib versus basiliximab for steroid-refractory acute graft-versus-host disease: a retrospective study.Ann Hematol2023https://conductscience.org/library/papers/37474631PubMed
36742189Machine learning algorithm as a prognostic tool for Epstein-Barr virus reactivation after haploidentical hematopoietic stem cell transplantation.Blood Sci2023https://conductscience.org/library/papers/36742189PubMed
36709164[Chinese consensus on the diagnosis and management of Epstein-Barr virus-related post-transplant lymphoproliferative disorders after hematopoietic stem cell transplantation (2022)].Zhonghua Xue Ye Xue Za Zhi2022https://conductscience.org/library/papers/36709164PubMed
36709144[The Chinese consensus on the management of cytomegalovirus infection in allogeneic hematopoietic stem cell transplantation patients (2022)].Zhonghua Xue Ye Xue Za Zhi2022https://conductscience.org/library/papers/36709144PubMed
36171605Cytomegalovirus infection may be oncoprotective against neoplasms of B-lymphocyte lineage: single-institution experience and survey of global evidence.Virol J2022https://conductscience.org/library/papers/36171605PubMed
36050712
Effect of sorafenib maintenance on Epstein-Barr virus and cytomegalovirus infections in patients with FLT3-ITD AML undergoing allogeneic hematopoietic stem cell transplantation: a secondary analysis of a randomized clinical trial.
BMC Med2022https://conductscience.org/library/papers/36050712PubMed
35615363The Incidence, Outcomes, and Risk Factors of Secondary Poor Graft Function in Haploidentical Hematopoietic Stem Cell Transplantation for Acquired Aplastic Anemia.Front Immunol2022https://conductscience.org/library/papers/35615363PubMed

See all 53 cited byDownload CSV of cited by

Genes8

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

Download CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/22856463

GET https://conductscience.org/api/papers/v1/22856463/references?page=2